An Alzheimer’s drug from Roche cleared a protein that’s a hallmark of the disease from patients’ brains, suggesting the drug ...

Early data suggest Roche’s antibody may safely and quickly remove amyloid plaque for patients with Alzheimer’s disease, though the mid-stage study has been tied to one death. | Early data suggest ...

An experimental Alzheimer’s therapy from Roche successfully cleared a protein that’s a hallmark of the disease from patients’ ...

An elderly patient died in a clinical study of Roche Holding AG’s experimental treatment for Alzheimer’s disease, prompting ...

Qure.ai partners with Roche Diagnostics APAC to develop AI-driven medical imaging technologies for healthcare innovation in ...

Roche recently joined naysayers who argue the deal threatens competition in the burgeoning weight loss and diabetes drug ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Roche Holding AG (RHHVF – Research Report) and Pfizer (PFE – ...

These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through ...

GeneDx Holdings stock has surged over 3,000% in the past year with promising earnings and market potential, but growth may be ...

In March Rachel Roche's achievements were once again in the spotlight as she came out on top in the Professional Services ...

The transaction, seen as a vote of confidence, has put the focus on other drug firms testing similar barrier-bridging ...

Roche revealed early-stage data for a new Alzheimer’s program on Wednesday as it seeks to jump back into a field littered ...